CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist

Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital ...
The American Journal of Managed Care

SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs

Although both sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...
Endocrinology Advisor

GLP-1 RAs Linked to Improved Survival in Patients With Cancer and T2D

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.
Neurology Advisor

FDA Finds No Causal Link Between GLP-1 RAs and Suicidal Behavior

FDA requests removal of suicidal ideation warnings from GLP-1 RA labels after meta-analysis shows no increased risk compared with placebo.
News-Medical.Net

Why exercise is essential for restoring fitness after GLP-1-based weight loss

This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, ...